HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer.
Cortesi M, Bravaccini S, Ravaioli S, Petracci E, Angeli D, Tumedei MM, Balzi W, Pirini F, Zanoni M, Possanzini P, Rocca A, Palleschi M, Ulivi P, Martinelli G, Maltoni R.
Cortesi M, et al. Among authors: rocca a.
Cancers (Basel). 2024 Nov 6;16(22):3752. doi: 10.3390/cancers16223752.
Cancers (Basel). 2024.
PMID: 39594707
Free PMC article.